Relationships between disability, quality of life and prevalence of nonmotor symptoms in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 18, Issue 1, 2012, Pages 35-39

  Leonardi, Matilde ^a   Raggi, Alberto ^a   Pagani, Marco ^a   Carella, Francesco ^a   Soliveri, Paola ^a   Albanese, Alberto ^a,b   Romito, Luigi ^a,b  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

Disability; Health related quality of life; Nonmotor symptoms; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSS SECTIONAL STUDY; DISABILITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON MOTOR SYMPTOMS QUESTIONNAIRE; OBSERVATIONAL STUDY; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SHORT FORM 36; SOCIAL PSYCHOLOGY; STUDENT T TEST; STUDY DESIGN; SYMPTOMATOLOGY; WORLD HEALTH ORGANIZATION DISABILITY ASSESSMENT SCHEDULE;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; QUALITY OF LIFE; YOUNG ADULT;

EID: 84655169232     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.08.011     Document Type: Article

References (29)

1. Bower J.H., Maraganore D.M., McDonnell S.D.K., Rocca W.A. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999, 52:1214-1220.
2. de Rijk M.C., Breteler M.M., Graveland G.A., Ott A., Grobbee D.E., van der Meché F.G., et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology 1995, 45:2143-2146.
3. Katzenschlager R., Head J., Schraq A., Ben-Shlomo Y., Evans A., Lees A.J. Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD. Neurology 2008, 71:474-480.
4. Lees A.J., Hardy J., Revesz T. Parkinson's disease. Lancet 2009, 373:2055-2066.
5. Post B., Merkus M.P., de Haan R.J., Speelman J.D. Prognostic factors for the progression of Parkinson's disease: a systematic review. Mov Disord 2007, 22:1839-1851. the CARPA Study Group.
6. Weintraub D., Moberg P.J., Duda J.E., Katz I.R., Stern M.B. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. JAm Geriatr Soc 2004, 52:784-788.
7. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
8. Shulman L.M., Gruber-Baldini A.L., Andreson K.E., Vaughan C.G., Reich S.G., Fishman P.S., et al. The evolution of disability in Parkinson disease. Mov Disord 2008, 23:790-796.
9. Muslimovic D., Post B., Speelman J.D., Schmand B., de Haan R.J. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology 2008, 70:2241-2247. CARPA Study Group.
10. Schrag A. Quality of life and depression in Parkinson's disease. JNeurol Sci 2006, 248:151-157.
11. Chaudhuri K.R., Healy D.G., Schapira A.H. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006, 5:235-245.
12. Clinical guideline. Parkinson's disease 2006, vol. 35. The National Institute for Clinical Excellence (NICE), Chapter 9, June. http://www.nice.org.uk/.
13. Martinez-Martin P., Schapira A.H., Stocchi F., Sethi K., Odin P., MacPhee G., et al. Prevalence of nonmotor symptoms in Parkinson's disease in an International setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007, 22:1623-1629.
14. Chaudhuri K.R., Martinez-Martin P., Schapira A.H., Stocchi F., Sethi K., Odin P., et al. International multicentre pilot study of the first comprehensive self-completed non motor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006, 21:916-923.
15. International classification of functioning, disability and health 2001, World Health Organization, World Health Organization, Geneva.
16. Raggi A., Leonardi M., Ajovalasit D., Carella F., Soliveri P., Albanese A., et al. Functioning and disability in Parkinson's disease. Disabil Rehabil 2010, 32:S33-S41.
17. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. JNeurol Neurosurg Psychiatry 1992, 55:181-184.
18. Ware J.E. SF-36 health survey update. Spine 2000, 25:3130-3139.
19. Ustün T.B., Chatterji S., Kostanjsek N., Rehm J., Kennedy C., Epping-Jordan J., et al. Developing the world health organization disability assessment schedule 2.0. Bull World Health Organ 2010, 88:815-823.
20. Garin O., Ayuso-Mateos J.L., Almansa J., Nieto M., Chatterji S., Vilagut G., et al. Validation of the world health organization disability assessment schedule (WHODAS-2) in patients with chronic diseases. Health Qual Life Outcomes 2010, 8:51.
21. Fisk J.D., Brown M.G., Sketris I.S., Metz L.M., Murray T.J., Stadnyk K.J. Acomparison of health utility measures for the evaluation of multiple sclerosis treatments. JNeurol Neurosurg Psychiatry 2005, 76:58-63.
22. Federici S., Meloni F., Mancini A., Lauriola M., Olivetti Belardinelli M. World health organisation disability assessment schedule II: contribution to the Italian validation. Disabil Rehabil 2009, 31:553-564.
23. Apolone G., Mosconi P. The Italian SF-36 health survey: translation, validation and norming. JClin Epidemiol 1998, 51:1025-1036.
24. Cronbach L.J. Coefficent alpha and the internal structure of tests. Psychometrika 1951, 16:297-334.
25. Leonardi M., Raggi A., Antozzi C., Confalonieri P., Maggi L., Cornelio F., et al. The relationship between health, disability and quality of life in Myasthenia Gravis: results from an Italian study. JNeurol 2010, 257:98-102.
26. Leonardi M., Raggi A., Bussone G., D'Amico D. Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache 2010, 50:1576-1586.
27. Duncan R.P., Earhart G.M. Measuring participation in individuals with Parkinson disease: relationships with disease severity, quality of life, and mobility. Disabil Rehabil 2011, 1440-1446.
28. Lindgren P., von Campenhausen S., Spottke E., Siebert U., Dodel R. Cost of Parkinson's disease in Europe. Eur J Neurol 2005, 12:68-73.
29. Brown C.A., Cheng E.M., Hays R.D., Vassar S.D., Vickrey B.G. SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures. Qual Life Res 2009, 18:1219-1237.